Correction to: Multidisciplinary treatment for locally advanced breast cancer with internal mammary lymph node metastasis in an elderly patient

Correction to: International Cancer Conference Journal (2019) 8:1–6 10.1007/s13691-018-0344-z

In the original publication, in Table 1, the patient 3, 58 years of age, was scheduled to be administered eribulin after gemcitabine as adjuvant therapy. However, the patient was deceased before administration due to sepsis. Eribulin was not administered actually and it needs to be deleted. The corrected Table 1 is given in this Correction.

Table 1.

Patient characteristics with internal mammary lymph node metastasis at diagnosis

Age	Clinical stage	Location	Subtype	Neoadjuvant therapy	Operation	Radiation	Adjuvant therapy	Outcome
42	T3N3bM0	Upper-lateral	Luminal-HER2	EC-wPTX + HCPT	Bp + SLNB	60 Gy/30fr	HCPT + TAM	SD
44	T4bN3bM1 (synchronous bilateral)	Upper-mediolateral	Luminal-HER2	TC	Bt	–	TAM + zometa-DTX + Per + HCPT + zometa	SD
58	T4bN2bM0 (SCC)	Upper-medial	Luminal A-like	EC-wPTX-VNR	Bp + Ax	50 Gy/25fr	DTX-TS-1 + ANA-GEM	Death due to sepsis
68	T2N3bM0	Lower-medial	Luminal B-like	wPTX	Bp + Ax	50 Gy/25fr	LET	SD
82	T2N3bM0	Upper-medial	Luminal B-like	–	Bp + Ax	60 Gy/30fr	UFT + LET	SD